ERBB2 and neoplasm: We found that the repression of tumour growth by PTPN2‐deficient CD8+ HER‐2 CAR T cells was accompanied by a marked increase in CD45+ CD8+ CD3+ mCherry+ CAR T‐cell abundance in tumours and the corresponding draining lymph nodes (Fig 6A).